The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma
暂无分享,去创建一个
T. Yen | C. Liao | Kai-Ping Chang | H. Kao | Yenlin Huang | M. Abdelrahman | W. Lao | Yousif I. Eltohami | Y. Eltohami
[1] Ying Sun,et al. Socioeconomic factors and survival in patients with non‐metastatic head and neck squamous cell carcinoma , 2017, Cancer science.
[2] Weijia Xie,et al. Association of Systemic Inflammation Score With Atrial Fibrillation: A Case-Control Study With Propensity Score Matching. , 2017, Heart, lung & circulation.
[3] Shulin Chen,et al. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma , 2016, International journal of molecular sciences.
[4] Moyi Sun,et al. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients , 2016, Oncotarget.
[5] Fei-yun Zheng,et al. Cervical cancer systemic inflammation score: a novel predictor of prognosis , 2016, Oncotarget.
[6] Jianqing Xu,et al. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma , 2015, British Journal of Cancer.
[7] J. Waldron,et al. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status , 2015, Cancer.
[8] D. McMillan,et al. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma. , 2015, The British journal of oral & maxillofacial surgery.
[9] K. Pummer,et al. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. , 2014, Urologic oncology.
[10] Jie-wen Peng,et al. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy , 2014, Tumor Biology.
[11] A. Gerger,et al. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas , 2014, International journal of cancer.
[12] J. Coffey,et al. Ratios derived from an array of standard haematological indices predict the oncological outcome in colon cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[13] R. Metgud,et al. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy , 2014, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[14] Kai-Ping Chang,et al. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma. , 2013, Oral oncology.
[15] V. Gebski,et al. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer , 2013, British Journal of Cancer.
[16] Kai-Ping Chang,et al. Pretreatment Interleukin-6 Serum Levels Are Associated with Patient Survival for Oral Cavity Squamous Cell Carcinoma , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[17] T. Yen,et al. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity. , 2011, International journal of radiation oncology, biology, physics.
[18] D. Talwar,et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.
[19] R. Lambert,et al. Epidemiology of cancer from the oral cavity and oropharynx , 2011, European journal of gastroenterology & hepatology.
[20] T. Yen,et al. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[21] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[22] D. McMillan. Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.
[23] S. Warnakulasuriya. Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.
[24] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[25] B. Aggarwal,et al. TNF: a master switch for inflammation to cancer. , 2008, Frontiers in bioscience : a journal and virtual library.
[26] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[27] D. Kyriakou,et al. Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer‐Related Thrombocytosis , 2003, American journal of clinical oncology.
[28] C. McArdle,et al. Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss , 2001, Nutrition and cancer.
[29] N. Soni,et al. Serum albumin: touchstone or totem? , 1998, Anaesthesia.
[30] N. Sakamoto,et al. Cancer-Specific Mortality and Competing Mortality in Patients with Head and Neck Squamous Cell Carcinoma: A Competing Risk Analysis , 2014, Annals of Surgical Oncology.
[31] Magdalena Kowalewska,et al. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation , 2010, Nature Reviews Cancer.
[32] D. Wilson,et al. The epidemiology of mouth cancer: a review of global incidence. , 2000, Oral diseases.